2011 ACRIN Annual Meeting ACRIN Accrual Committee ACRIN 2011 Fall Meeting Reginald F. Munden.

Slides:



Advertisements
Similar presentations
Martin E. Gutierrez, MD Recruitment Experience in a Phase 0 Trial of ABT-888, an Inhibitor of Poly (ADP- ribose) Polymerase (PARP), in Patients With Advanced.
Advertisements

Easing the Trauma of Faculty Suicide: the Use of a Crisis Protocol in an Academic Medical Center Georgia Thomas, MD, MPH, Warren Holleman, PhD, John Hyatt,
Presentation Name Recruitment and Accrual of Special Populations Special Population Committee Elizabeth A. Patterson M.D., Chair.
ACRIN 6698 Protocol: Diffusion-weighted MR Imaging Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: A sub-study of the ISPY-2.
2011 ACRIN Annual Meeting Washington University, PIs: Pamela Woodard, M.D. Tammie Benzinger, M.D. Hypothesis: Availability of a coordinator and technologist.
2011 ACRIN Annual Meeting Proposal for facilitating protocol development and site pre-activation Suzanne L. Palmer, M.D. Tammie Possemato Chaan Ng, M.D.
Research Protocol ACRIN 6678 Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
ACRIN 6687 A Phase 2, Multicenter Evaluation of 18 F-Fluoride PET as a Pharmacodynamic Biomarker for Dasatinib, a Src Kinase Inhibitor, in Men With Castration-Resistant.
CALGB Informational Session June 22, 2007 David Hurd, MD Interim Chair Data Audit Committee.
The Sanford World Clinics October, Brief History 116-year history with foundations in Sioux Falls, South Dakota and Fargo, North Dakota Sanford.
Consent for Research Study A study for patients with a diagnosis of liver cancer who are on the waiting list for a liver transplant Comparison of advanced.
ACRIN Research Associates Educational Session Radiation Therapy Oncology Group Research Associates Committee Joyce Neading, RHIT, CTR Program Director,
Maryland Cancer Plan Pain Management Committee Suzanne A Nesbit, PharmD, BCPS Clinical Coordinator, Cancer Pain Service Sidney Kimmel Comprehensive Cancer.
IRB and the Community Member How You Can Get Involved Mary Lou Smith Elda Railey Conference Call Series on IRBs and Ethical Issues in Research Co-sponsored.
Assessing Minority Participation in Clinical Trials: Setting Attainable Goals The Minority and Women Clinical Trials Recruitment Program Department of.
ACRIN 6678 Site Training ACRIN 6678 FDG-PET/CT as a Predictive Marker of Tumor Response and Patient Outcome: Prospective Validation in Non-small Cell Lung.
Annual Meeting 2011 Clinical Trial Development Clinical Trial Development: OEWG, RA’s Role, and Activating Trials on Deadline Martha Heckel Protocol Associate.
ACRIN 6673 Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in Cirrhotic Patients: A Multi-Center Study.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
1 Targeted Strategies to Improve Physician and Patient Access to Cancer Clinical Research An Overview of Coalition Programs and Services Ruth Lambersky.
2011 ACRIN Annual Meeting ACRIN ACCELERATED ACCRUAL DEMONSTRATION PROJECT Department of Radiology The University of Iowa Carol Mertens, Ph.D., CFLE, LMHC.
1 The Role of Stakeholders in the Diabetes Multi-Center Research Consortium (DMCRC) Joe V Selby MD, Director DMCRC Coordinating Center Kaiser Permanente.
Study Accrual… Recruiting Across the Spectrum ACRIN – RA Education Session September 29, 2010 Pentagon City, VA Lorna Beccaria, RN, BSN, CCRC.
ACRIN Fall Meeting 2008 Mitchell Schnall MD, PhD Professor of Radiology University of Pennsylvania ACRIN Network Chair State of ACRIN : 10 years of investment.
ACRIN 6678 Site Training ACRIN 6678 FDG-PET/CT as a Predictive Marker of Tumor Response and Patient Outcome: Prospective Validation in Non-small Cell Lung.
2011 ACRIN Annual Meeting The ACRIN Accrual Project at University of Washington Constance Lehman, MD. PhD David Mankoff, MD. PhD Tiffany Wong, MS.
State of ACRIN : Extending our reach
Elizabeth A. Martinez, MD, MHS Johns Hopkins Medical Institutions September 10, 2008 Organization of Care and Outcomes in Cardiac Surgery AHRQ grant 1K08HS A1.
ACRIN 6685 Overview ACRIN 6685 A Multi-center Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head.
Imaging Core Laboratory Fall Meeting, 2011 Imaging Challenges for ACRIN sites Compliance and set-up Anthony M. Levering Assistant Director, Core lab.
Sanford USD Medical Center Sioux Falls, SD Becky Nelson, Senior VP & COO Health Service Operations Sanford Health.
The SNM Centralized IND & Clinical Trials Network Enabling Implementation Investigational & Approved PET Imaging in Multicenter Clinical Trials George.
Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.
CTOS IS TEN YEARS OLD SARC IS TWO YEARS OLD Happy Birthday, CTOS, SARC.
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 9/30/10.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
ACRIN – Ten Excellent Years ACRIN RA Sessions Specificity Sensitivity.
Consent for Research Study A study using 18 F-Fluoride for prostate cancer patients currently enrolled in Dr. Febbo’s “Genomic Guided Therapy” study A.
Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Malignant Peripheral Nerve Sheath Tumors Brigitte Widemann,
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
American College of Radiology Imaging Network ACRIN 6664 ACRIN 6664 – Protocol Review The National CT Colonography Trial Name(s) of presenters.
Research Orientation to SCCA. What is the SCCA? The SCCA brings together the outstanding adult and pediatric oncology patient care services of three world-
Getting a study done at Jefferson:. Startup Activities: Image courtesy of CITI Program Clinical Research Coordinator course.
Progress of the SNM Clinical Trials Network Michael Graham, PhD, MD Clinical Trials Network Co-Chair SNM President 1.
Enrollment and Monitoring Procedures for NCI Supported Clinical Trials Barry Anderson, MD, PhD Cancer Therapy Evaluation Program National Cancer Institute.
Role of the Drug Project Team in Formulating the Initial Development Plan of NCI-IND agents Jeff Moscow, MD IDB, CTEP.
Clinical Trials Design, Development, and Outreach Working Group Richard L. Wahl, M.D. & John Buatti, M.D.
AccrualNet: A New NCI Tool for Supporting Accrual to Clinical Trials Linda Parreco, RN, MS NCI, Office of Communication and Education September 29, 2010.
The President’s Cancer Panel 2004/2005 Series Translating Research to Reduce the Burden of Cancer Margaret L. Kripke, Ph.D. January 25, 2005.
Uses of the NIH Collaboratory Distributed Research Network Jeffrey Brown, PhD for the DRN Team Harvard Pilgrim Health Care Institute and Harvard Medical.
Florida Cancer Plan Phil Roland, MD FACS FACOG Florida State Chair A Commission on Cancer.
The Interface between Primary Care and Specialty Care in Primary Treatment of Cancer Jonathan Sussman Supportive Cancer Care Research Unit Laura-Mae Baldwin.
ACRIN EISC Experimental Imaging Sciences Committee (EISC) David Mankoff, MD, PhD Experimental Imaging Sciences Committee Chair Professor of Radiology University.
Dr. Sabine Brookman-May, MD, PhD Regional Therapeutic Area Expert Oncology (Europe, Middle East, Africa) - Janssen R&D Improving patients involvement in.
Dr. Rachel Syme AD, Institute of Cancer Research, CIHR Dr. Bernie Eigl Provincial Director, Clinical Trials, BCCA Incremental Costs of Cancer Clinical.
This study is funded by a contract from the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Cancer.
Cancer Prevention Clinical Trials at [Name of Clinical Site]
Patient Focused Drug Development An FDA Perspective
How to Find and Participate in a GIST clinical trial
Study Feasibility and Start-up
How to Navigate the NCTN and Participate in Imaging Research
Developing a Comprehensive Site Selection Process for a Cancer Network in a Resource-Limited Settings in Sub-Saharan Africa Meg Wirth AMC Operations &
Learning About PET/CT Scans:
Getting a Study Done at Jefferson:
Provider Resistance to Pathways Physician Buy-In & Adoption
Clinical Trial Development: RA’s Role, OEWG, and IRB Submissions Martha Heckel Protocol Associate, ACRIN Dept. of Protocol Development & Regulatory.
Patient Engagement through Social Media for Clinical Trials
Presentation transcript:

2011 ACRIN Annual Meeting ACRIN Accrual Committee ACRIN 2011 Fall Meeting Reginald F. Munden

2011 ACRIN Annual Meeting ACRIN Accrual Committee Reginald Munden, MD (Thoracic Committee) MDACC Hiroyuki Abe, MD (Breast Committee) - University of Chicago Peggy Anthony (Patient Advocacy Committee Chair) Lorna Beccaria (RA Executive Committee) Sanford Jeames (Patient Advocacy Committee) Suzanne Lenz (RA Executive Committee) - Darthmoth Barbara Galen (NCI Rep) Frank Lin (NCI Rep) Chaan Ng, MD (GYN Committee) - MDACC Rathan Subramaniam, MD (Head/Neck/Neuro Committee) – Boston University Betty Patterson, MD (Patient Advocacy / Special Populations Committee Chair) - Retired Tracy Petro (RA Executive Committee) - Springfield, IL Michael Yu, MD (Experimental Imaging Science Committee) - Fox Chase Nancy Fredericks - ACRIN

ACRIN Accrual Committee Goal: 1.To improve recruitment of institutions and investigators (site recruitment) into ACRIN clinical trials. 2.To improve participant enrollment (patient recruitment) into ACRIN clinical trials. Deliverables: Recommendations to improve participation by institutions and sites Methods/strategies to improve patient recruitment into clinical trials Data and information to incorporate into clinical trials to ensure recruitment

ACRIN Accrual Committee Site Recruitment – Site issues – Physician/Radiologists issues Patient Recruitment – Science/Protocol related – Patient Related – Referring physician related

Accrual Committee Site Recruitment – Site Issues Start Up Funding - Institutions require funds to cover costs of the trial prior to initiation. ACRIN reimbursement is typically not funded until patients are enrolled. Sites need to be capable of performing the patient enrollment process and imaging requirements, but they may not be familiar with the specific needs to accomplish the trial. Competing clinical trials limits resources. Lack of resources to conduct imaging trial (equipment, technologists, assistants).

Accrual Committee Site Recruitment – Physician Issues Site PI for ACRIN trial does not receive recognition for their efforts and time by Chair, Institution, or NCI. Lack of excitement by radiologist for ACRIN trial. Lack of knowledge regarding importance of ACRIN. Lack of understanding the time and resource commitment needed by PI. Lack of engagement by referring physicians.

Accrual Committee Patient Recruitment – Science/Protocol The complexity of imaging protocols – especially very ill patients Increased focus on biomarkers requires biopsies/molecular staining and pathology support Trials often demand single therapy to limit impact of imaging results, but institutions are typically ones offering multiple therapies Coordinating access to an imaging agent (FLT/FMISO) impacts activation Timing of imaging and scanner access has a significant impact on accrual Cost of imaging - often costs for imaging far exceed funding

Accrual Committee Patient Recruitment – Patient Related Potential participants, especially cancer patients, are overwhelmed with their diagnosis and not receptive to a study that delays treatment Imaging studies offer little to no directly obvious patient benefit Patients prefer to have scanning close to home. ACRIN study may require imaging that is only available at large medical center

Accrual Committee Patient Recruitment – Referring Physician Need buy in from referring physician Referring clinician perception of value of the imaging in the trial. Lack of coordination and awareness of studies within and between departments in a given institution. Time to introduce a clinical trial is challenging in a busy clinic setting.

ACRIN Accrual Committee Demonstration Projects Suzanne Palmer, MD/ Chan Ng - University of Southern California / MD Anderson Pamela Woodard, MD - Washington University Carol Mertens, PhD - University of Iowa David Mankoff, MD, PhD /Connie Lehman MD, PhD- University of Washington